Noticeably, the oncogenic course might be more complicated as it has been reported in other cancers (see further) that invasiveness was either associated with FOXP2 up-regulation as in prostate cancer [13] or, conversely, with FOXP2 down-regulation as reported for breast cancer [9]. This evidence concerns the gene FOXP2 and prostate cancer.